title: Acquired myeloma-associated Type III hyperlipidaemia treated by nonmyeloablative HLA-identical sibling allogeneic stem cell transplant using a donor with essential thrombocythaemia (ET): evidence of engraftment without manifestation of ET in recipient.
authors.forename: L
authors.initials: L
authors.lastname: Chee
authors.forename: R L
authors.initials: RL
authors.lastname: Spearing
authors.forename: C M
authors.initials: CM
authors.lastname: Morris
authors.forename: M
authors.initials: M
authors.lastname: McDonald
authors.forename: V
authors.initials: V
authors.lastname: Hanrahan
authors.forename: A
authors.initials: A
authors.lastname: Ebbett
authors.forename: R
authors.initials: R
authors.lastname: Scott
authors.forename: C
authors.initials: C
authors.lastname: Florkowski
authors.forename: T
authors.initials: T
authors.lastname: Walmsley
authors.forename: W N
authors.initials: WN
authors.lastname: Patton
mesh_terms: D005260:Female; D006085:Graft Survival; D018380:Hematopoietic Stem Cell Transplantation / Q000379:methods*; D006801:Humans; D006952:Hyperlipoproteinemia Type III / Q000209:etiology*; D008297:Male; D008875:Middle Aged; D009101:Multiple Myeloma / Q000150:complications*; D035781:Siblings; D013920:Thrombocythemia, Essential; D014019:Tissue Donors; D014184:Transplantation, Homologous